Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.040 AUD
−17.08 M AUD
407.47 K AUD
414.96 M
About DIMERIX LIMITED
Sector
CEO
Nina Webster
Headquarters
Melbourne
Website
Founded
1975
ISIN
AU000000DXB7
FIGI
BBG000BQ99B8
Dimerix Ltd. engages in the investment of the research and development of biopharmaceutical drugs. It focuses on the development of Dimerix DMX-200 drug candidate in both renal and respiratory indications and the development of Dimerix DMX-700 pre-clinical asset in Chronic Obstructive Pulmonary Disease. The company was founded on May 13, 1975 and is headquartered in Melbourne, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of DXB is 0.365 AUD — it has increased by 8.96% in the past 24 hours. Watch DIMERIX LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange DIMERIX LIMITED stocks are traded under the ticker DXB.
DXB stock has risen by 10.61% compared to the previous week, the month change is a −8.75% fall, over the last year DIMERIX LIMITED has showed a 160.71% increase.
We've gathered analysts' opinions on DIMERIX LIMITED future price: according to them, DXB price has a max estimate of 0.91 AUD and a min estimate of 0.91 AUD. Watch DXB chart and read a more detailed DIMERIX LIMITED stock forecast: see what analysts think of DIMERIX LIMITED and suggest that you do with its stocks.
DXB stock is 8.82% volatile and has beta coefficient of 2.50. Track DIMERIX LIMITED stock price on the chart and check out the list of the most volatile stocks — is DIMERIX LIMITED there?
Today DIMERIX LIMITED has the market capitalization of 186.87 M, it has decreased by −13.33% over the last week.
Yes, you can track DIMERIX LIMITED financials in yearly and quarterly reports right on TradingView.
DIMERIX LIMITED is going to release the next earnings report on Mar 3, 2025. Keep track of upcoming events with our Earnings Calendar.
DXB net income for the last half-year is −10.40 M AUD, while the previous report showed −6.67 M AUD of net income which accounts for −55.88% change. Track more DIMERIX LIMITED financial stats to get the full picture.
No, DXB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DXB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DIMERIX LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DIMERIX LIMITED technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DIMERIX LIMITED stock shows the buy signal. See more of DIMERIX LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.